Cylanic 50 mg + 12.5 mg tablets for dogs and cats
Cylanic 50 mg + 12.5 mg tablets for dogs and cats
Authorised
This information is not available for this product.
Product identification
Medicine name:
Cylanic 50 mg + 12.5 mg tablets for dogs and cats
CYLANIC 50 mg + 12,5 mg tabletta kutyák és macskák részére A.U.V.
Active substance:
This information is not available for this product.
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CR02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Hungary
Available in:
-
Hungary
Package description:
- oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each.Package sizes:Cardboard box of 250 tablets.
- oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each.Package sizes:Cardboard box of 100 tablets.
- oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each.Package sizes:Cardboard box of 50 tablets.
- oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each.Package sizes:Cardboard box of 30 tablets.
- oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each.Package sizes:Cardboard box of 10 tablets.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Livisto Int'l S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
- Animedica GmbH
- Lelypharma B.V.
- Animedica Herstellungs GmbH
- Industrial Veterinaria S.A.
Responsible authority:
- Directorate Of Veterinary Medicinal Products
Authorisation number:
- 4298/X/21 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0582/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Estonia
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: